Glioblastoma (GBM) Awareness Day
Wednesday, July 20, 2022
Today, we shine a light on glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer.
What is Glioblastoma Awareness Day?
On July 20, 2022, we shine a light on glioblastoma (GBM), the most common, complex, treatment-resistant, and deadliest type of brain cancer. National Brain Tumor Society spearheaded this annual event in 2019 to support survivors and their loved ones, remember those who are no longer with us, and honor luminaries working toward a cure and better quality of life for those who are living with this devastating disease. This year, the National Brain Tumor Society will virtually gather leading researchers, members of Congress, patients, caregivers, and friends for a day of educational programming, community discussions, and more.
WATCH #GBMDAY
We will not stop until we cast a national light on this devastating disease. Take action to propel research and treatments forward. Join our virtual GBM Day event and get answers to your GBM questions.
RAISE AWARENESS
Shine a light on the realities of a GBM diagnosis. Share your story and show others that they are not alone. Spread the word on social media with GBM statistics and shareable graphics, and become an advocate.
MAKE A GIFT
Your support is critical to ensuring the urgent, unmet needs of the brain tumor community continue to be heard and addressed. When you make a one-time or sustaining gift to NBTS, you have an immediate impact on the important work underway to conquer and cure brain tumors—once and for all.
GBM By the Numbers
More than 13,400 Americans will receive a glioblastoma diagnosis in 2022.
The five-year survival rate for glioblastoma patients is only 6.8% and the median length of survival is only 8 months.
Brain tumors, including glioblastoma, represent the highest per-patient initial cost of care for any cancer group, with an annualized mean net cost of care approaching $150,000.
It is estimated that more than 10,000 Americans will succumb to glioblastoma every year.
Despite first being identified in scientific literature in the 1920s, there are only five FDA approved drugs – and one device – to treat glioblastoma.
Cast a light on this devastating disease and conquer and cure GBM—once and for all. This #GBMDay, take action to propel research and treatments forward.
Voices of Support from our Community
American Association of Neurological Surgeons
GT Medical Technologies
IQVIA
UCSF
Our Partners
Thank you for joining us to shine a light on GBM.
